|
DNMT3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.960800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.493800E-01 |
| Normal-vs-Stage2 |
4.189000E-01 |
| Normal-vs-Stage3 |
3.013000E-01 |
| Normal-vs-Stage4 |
4.280400E-01 |
| Stage1-vs-Stage2 |
8.979200E-01 |
| Stage1-vs-Stage3 |
7.859800E-01 |
| Stage1-vs-Stage4 |
9.669200E-01 |
| Stage2-vs-Stage3 |
9.457000E-01 |
| Stage2-vs-Stage4 |
9.384800E-01 |
| Stage3-vs-Stage4 |
8.652000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.290800E-01 |
| Normal-vs-AfricanAmerican |
4.392400E-01 |
| Normal-vs-Asian |
1.771980E-02 |
| Caucasian-vs-AfricanAmerican |
9.909000E-01 |
| Caucasian-vs-Asian |
2.257800E-03 |
| AfricanAmerican-vs-Asian |
2.009700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.313440E-01 |
| Normal-vs-Female |
8.672800E-01 |
| Male-vs-Female |
6.615600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.704400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.496000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.812240E-01 |
| Normal-vs-Age(81-100Yrs) |
2.553700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.635370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.278200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.497800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.687400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.387800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.260180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.494600E-01 |
| Normal-vs-Grade 2 |
4.972600E-01 |
| Normal-vs-Grade 3 |
1.262010E-01 |
| Normal-vs-Grade 4 |
8.700600E-01 |
| Grade 1-vs-Grade 2 |
1.913230E-01 |
| Grade 1-vs-Grade 3 |
8.203700E-02 |
| Grade 1-vs-Grade 4 |
3.010600E-01 |
| Grade 2-vs-Grade 3 |
2.186400E-01 |
| Grade 2-vs-Grade 4 |
6.218400E-01 |
| Grade 3-vs-Grade 4 |
1.713220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.106410E-01 |
| Normal-vs-ccB subtype |
9.452600E-01 |
| ccA subtype-vs-ccB subtype |
7.716200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.894800E-01 |
| Normal-vs-N1 |
6.756800E-01 |
| N0-vs-N1 |
3.620600E-01 |
|
|
